CSF Cytokines in Aging, Multiple Sclerosis, and Dementia
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Inflammation is a common process involved in aging, multiple sclerosis (MS), and age-related neurodegenerative disorders such as Alzheimer's disease (AD) and Parkinson's disease (PD), but there is limited evidence for the effects of aging on inflammation in the central nervous system. We collected cerebrospinal fluid (CSF) from 105 healthy control subjects representing a wide age range (23-86), and analyzed levels of cytokines associated innate immunity (TNF-α) and different T-helper subtypes: interferon-gamma induced protein 10 (IP-10) for Th1, interleukin-10 (IL-10) for Th2, and interleukin 8 (IL-8/CXCL8) for Th17. We show that CSF levels of TNF-α, IP-10, and IL-8 all increased linearly with age, but levels of IL-10 demonstrated a U-shaped relationship with age. We further found greater age-related increases in TNF-α, IL-10, and IL-8 relative to increases in IP-10 levels, consistent with a shift from Th1 to other inflammatory phenotypes. Finally, when we analyzed the same four cytokines in people with neurological disorders, we found that MS and AD, but not PD or dementia with Lewy bodies, further accentuated the age-related shift from Th1- to non-Th1-related cytokines. We propose that CSF cytokine levels represent powerful surrogates of brain inflammation and aging, and some, but not all, neurological disorders accelerate the shift away from Th1 phenotypes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria
Polman, C. H., Reingold, S. C., Banwell, B., Clanet, M., Cohen, J. A., Filippi, M., Fujihara, K., Havrdova, E., Hutchinson, M., Kappos, L., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22366 · Cited by 9,802
MDS clinical diagnostic criteria for Parkinson’s disease
Postuma, R. B., Berg, D., Stern, M., Poewe, W., Olanow, C. W., Oertel, W., Obeso, J., Marek, K., Litvan, I., Lang, A. E., et al. (2015) · Movement Disorders · doi:10.1002/mds.26424 · Cited by 7,653
Inflamm‐aging: An Evolutionary Perspective on Immunosenescence
FRANCESCHI, C., BONAFÈ, M., VALENSIN, S., OLIVIERI, F., DE LUCA, M., OTTAVIANI, E., & DE BENEDICTIS, G. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06651.x · Cited by 5,358 · cited 1×
“themselves bias the immune system and therefore cytokine levels, including aging-associated pro-inflammatory bias and a shift from Th1 to Th2/innate immunity dominance (6, 7).”
BackgroundDiagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium
McKeith, I. G., Boeve, B. F., Dickson, D. W., Halliday, G., Taylor, J.-P., Weintraub, D., Aarsland, D., Galvin, J., Attems, J., Ballard, C. G., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004058 · Cited by 4,476
Chronic Inflammation (Inflammaging) and Its Potential Contribution to Age-Associated Diseases
Franceschi, C., & Campisi, J. (2014) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glu057 · Cited by 3,891
Inflammaging: a new immune–metabolic viewpoint for age-related diseases
Franceschi, C., Garagnani, P., Parini, P., Giuliani, C., & Santoro, A. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0059-4 · Cited by 3,586
Through Ageing, and Beyond: Gut Microbiota and Inflammatory Status in Seniors and Centenarians
Biagi, E., Nylund, L., Candela, M., Ostan, R., Bucci, L., Pini, E., Nikkïla, J., Monti, D., Satokari, R., Franceschi, C., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010667 · Cited by 1,483
Primary age-related tauopathy (PART): a common pathology associated with human aging
Crary, J. F., Trojanowski, J. Q., Schneider, J. A., Abisambra, J. F., Abner, E. L., Alafuzoff, I., Arnold, S. E., Attems, J., Beach, T. G., Bigio, E. H., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1349-0 · Cited by 1,467
Age and Age-Related Diseases: Role of Inflammation Triggers and Cytokines
Rea, I. M., Gibson, D. S., McGilligan, V., McNerlan, S. E., Alexander, H. D., & Ross, O. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00586 · Cited by 1,267
Research works printed but not linked: 38
- Lapenna, 2018, Perivascular macrophages in health and disease, Nat Rev Immunol., 18, 689, 10.1038/s41577-018-0056-9 · DOI · Paper page
- Skaper, 2018, An Inflammation-centric view of neurological disease: beyond the neuron, Front Cell Neurosci., 12, 72, 10.3389/fncel.2018.00072 · DOI · Paper page
- Hu, 2010, Novel CSF biomarkers for Alzheimer's disease and mild cognitive impairment, Acta Neuropathol., 119, 669, 10.1007/s00401-010-0667-0 · DOI · Paper page
- Sandmand, 2002, Is ageing associated with a shift in the balance between Type 1 and Type 2 cytokines in humans?, Clin Exp Immunol., 127, 107, 10.1046/j.1365-2249.2002.01736.x · DOI · Paper page
- Hu, 2015, CSF beta-amyloid 1-42 - what are we measuring in Alzheimer's disease?, Ann Clin Transl Neurol., 2, 131, 10.1002/acn3.160 · DOI
- Howell, 2016, Research lumbar punctures among African Americans and Caucasians: perception predicts experience, Front Aging Neurosci., 8, 296, 10.3389/fnagi.2016.00296 · DOI · Paper page
- Howell, 2017, Race modifies the relationship between cognition and Alzheimer's disease cerebrospinal fluid biomarkers, Alzheimers Res Ther., 9, 88, 10.1186/s13195-017-0315-1 · DOI · Paper page
- Gangishetti, 2018, Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer's disease, Alzheimers Res Ther., 10, 98, 10.1186/s13195-018-0426-3 · DOI
- Clark, 2007, How TNF was recognized as a key mechanism of disease, Cytokine Growth Factor Rev., 18, 335, 10.1016/j.cytogfr.2007.04.002 · DOI · Paper page
- Hunt, 2003, Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria, Trends Immunol., 24, 491, 10.1016/S1471-4906(03)00229-1 · DOI · Paper page
- Pelletier, 2010, Evidence for a cross-talk between human neutrophils and Th17 cells, Blood., 115, 335, 10.1182/blood-2009-04-216085 · DOI · Paper page
- Haabeth, 2011, Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer, Nat Commun., 2, 240, 10.1038/ncomms1239 · DOI · Paper page
- Craig-Schapiro, 2011, Multiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer's disease diagnosis and prognosis, PLoS ONE., 10.1371/journal.pone.0018850 · DOI · Paper page
- Uzawa, 2009, Markedly increased CSF interleukin-6 levels in neuromyelitis optica, but not in multiple sclerosis, J Neurol., 256, 2082, 10.1007/s00415-009-5274-4 · DOI
- Horellou, 2015, Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis, J Neuroimmunol., 289, 1, 10.1016/j.jneuroim.2015.10.002 · DOI
- Matejcikova, 2015, Cerebrospinal fluid inflammatory markers in patients with multiple sclerosis: a pilot study, J Neural Transm., 122, 273, 10.1007/s00702-014-1244-9 · DOI
- Sosvorova, 2015, The comparison of selected cerebrospinal fluid and serum cytokine levels in patients with multiple sclerosis and normal pressure hydrocephalus, Neuro Endocrinol Lett., 36, 564, 10.1046/j.1365-2249.2002.01736.x · DOI · Paper page
- Nevalainen, 2015, Transcriptomic and epigenetic analyses reveal a gender difference in aging-associated inflammation: the vitality 90+ study, Age., 37, 9814, 10.1007/s11357-015-9814-9 · DOI
- Pangrazzi, 2017, Inflamm-aging influences immune cell survival factors in human bone marrow, Eur J Immunol., 47, 481, 10.1002/eji.201646570 · DOI · Paper page
- Rhinn, 2017, Differential aging analysis in human cerebral cortex identifies variants in TMEM106B and GRN that regulate aging phenotypes, Cell Syst., 4, 404, 10.1016/j.cels.2017.02.009 · DOI · Paper page
- Cheng, 2018, Repression of human and mouse brain inflammaging transcriptome by broad gene-body histone hyperacetylation, Proc Natl Acad Sci USA., 115, 7611, 10.1073/pnas.1800656115 · DOI
- Fainardi, 2003, Presence of detectable levels of soluble HLA-G molecules in CSF of relapsing-remitting multiple sclerosis: relationship with CSF soluble HLA-I and IL-10 concentrations and MRI findings, J Neuroimmunol., 142, 149, 10.1016/S0165-5728(03)00266-2 · DOI
- Braitch, 2008, Increased osteopontin levels in the cerebrospinal fluid of patients with multiple sclerosis, Arch Neurol., 65, 633, 10.1001/archneur.65.5.633 · DOI · Paper page
- Maxeiner, 2014, Cerebrospinal fluid and serum cytokine profiling to detect immune control of infectious and inflammatory neurological and psychiatric diseases, Cytokine., 69, 62, 10.1016/j.cyto.2014.05.008 · DOI
- Cossburn, 2012, Age at onset as a determinant of presenting phenotype and initial relapse recovery in multiple sclerosis, Mult Scler., 18, 45, 10.1177/1352458511417479 · DOI · Paper page
- Roy, 2017, Differential effects of aging on motor and cognitive functioning in multiple sclerosis, Mult Scler., 23, 1385, 10.1177/1352458516679036 · DOI
- Sawcer, 2011, The major cause of multiple sclerosis is environmental: genetics has a minor role–no, Mult Scler., 17, 1174, 10.1177/1352458511421106 · DOI
- Maimone, 1991, Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis, J Neuroimmunol., 32, 67, 10.1016/0165-5728(91)90073-G · DOI · Paper page
- Sorensen, 1999, Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients, J Clin Invest., 103, 807, 10.1172/JCI5150 · DOI · Paper page
- Narikawa, 2004, CSF chemokine levels in relapsing neuromyelitis optica and multiple sclerosis, J Neuroimmunol., 149, 182, 10.1016/j.jneuroim.2003.12.010 · DOI
- Rossi, 2014, Tumor necrosis factor is elevated in progressive multiple sclerosis and causes excitotoxic neurodegeneration, Mult Scler., 20, 304, 10.1177/1352458513498128 · DOI
- de, 2018, Immunological profile in cerebrospinal fluid of patients with multiple sclerosis after treatment switch to rituximab and compared with healthy controls, PLoS ONE., 13, e0192516, 10.1371/journal.pone.0192516 · DOI
- Rodriguez-Sainz, 2002, Th1/Th2 cytokine balance and nitric oxide in cerebrospinal fluid and serum from patients with multiple sclerosis, Eur Cytokine Netw., 13, 110
- Khademi, 2000, Reduction of both pro- and anti-inflammatory cytokines after 6 months of interferon beta-1a treatment of multiple sclerosis, J Neuroimmunol., 103, 202, 10.1016/S0165-5728(99)00184-8 · DOI
- Mellergard, 2010, Natalizumab treatment in multiple sclerosis: marked decline of chemokines and cytokines in cerebrospinal fluid, Mult Scler., 16, 208, 10.1177/1352458509355068 · DOI · Paper page
- Mrak, 1997, Aging-associated changes in human brain, J Neuropathol Exp Neurol., 56, 1269, 10.1097/00005072-199712000-00001 · DOI · Paper page
- Ma, 2017, Outflow of cerebrospinal fluid is predominantly through lymphatic vessels and is reduced in aged mice, Nat Commun., 8, 1434, 10.1038/s41467-017-01484-6 · DOI · Paper page
- Thewissen, 2005, Premature immunosenescence in rheumatoid arthritis and multiple sclerosis patients, Ann N Y Acad Sci., 1051, 255, 10.1196/annals.1361.066 · DOI · Paper page
Cited by
Inflammaging and Oxidative Stress in Human Diseases: From Molecular Mechanisms to Novel Treatments
Zuo, L., Prather, E. R., Stetskiv, M., Garrison, D. E., Meade, J. R., Peace, T. I., & Zhou, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184472 · Cited by 539
Inflammatory Processes in Alzheimer’s Disease—Pathomechanism, Diagnosis and Treatment: A Review
Twarowski, B., & Herbet, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076518 · Cited by 412
Aging Biomarker Consortium, Bao, H., Cao, J., Chen, M., Chen, M., Chen, W., Chen, X., Chen, Y., Chen, Y., Chen, Y., et al. (2023) · Science China Life Sciences · doi:10.1007/s11427-023-2305-0 · Cited by 376
Innate Immune Cell Death in Neuroinflammation and Alzheimer’s Disease
Rajesh, Y., & Kanneganti, T.-D. (2022) · Cells · doi:10.3390/cells11121885 · Cited by 262
The killifish visual system as an in vivo model to study brain aging and rejuvenation
Vanhunsel, S., Bergmans, S., Beckers, A., Etienne, I., Van houcke, J., Seuntjens, E., Arckens, L., De Groef, L., & Moons, L. (2021) · npj Aging and Mechanisms of Disease · doi:10.1038/s41514-021-00077-4 · Cited by 58
Metadata
- Authors
- Hu, W. T., Howell, J. C., Ozturk, T., Gangishetti, U., Kollhoff, A. L., Hatcher-Martin, J. M., Anderson, A. M., & Tyor, W. R.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2019-03-15
- Volume
- 10
- Pages
- 480-480
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2922712727
- Cited by
- 122
- References
- 21
- FWCI
- 5.64
- Type
- journal article
- Language
- en
- Open access
- gold
- Funders
- National Institutes of Health (I01BX01506, K23AG042856, K23MH095679, R01AG054046, R01MH116695, R21AG043885)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: CSF Cytokines in Aging, Multiple Sclerosis, and Dementia. https://app.cochat.ai/papers/10.3389/fimmu.2019.00480
- The paper
- Hu, W. T., Howell, J. C., Ozturk, T., Gangishetti, U., Kollhoff, A. L., Hatcher-Martin, J. M., Anderson, A. M., & Tyor, W. R. (2019). CSF Cytokines in Aging, Multiple Sclerosis, and Dementia. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2019.00480
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.